Concepedia

Author

W L van Putten

Rotterdam University of Applied Sciences

Also Known As

W L van Putten, W.L Van Putten, W.L van Putten, Wim L. van Putten, Wim LJ van Putten

26

Publications

4.8K

Citations

18

H-Index

39

Concepts

All Affiliations

Rotterdam University of Applied Sciences
WL

About

W L van Putten is an author at Rotterdam University of Applied Sciences specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

4K

2

Health Sciences

2

2

1.1K

3

Immunology

2

2

324

4

Cell Biology

1

1

174

5

Endocrinology

1

1

117

W L van Putten

×

19

Publications

4.8K

Citations

18

H-Index

YearCitations

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial

Carien L. Creutzberg, W L van Putten, P. Koper,

The Lancet

2000

1.7K

Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial

Jacoba van der Zee, Dionisio González, Gerard C. van Rhoon,

The Lancet

2000

936

Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients.

John A. Foekens, Manfred Schmitt, W L van Putten,

PubMed

1992

231

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.

John A. Foekens, Manfred Schmitt, W L van Putten,

Journal of Clinical Oncology

1994

225

Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer.

John A. Foekens, Henk Portengen, W L van Putten,

PubMed

1989

219

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.

E. Berns, J.G.M. Klijn, W L van Putten,

PubMed

1992

206

The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients.

Charles J. Vecht, C. J. J. Avezaat, W L van Putten,

Journal of Neurology Neurosurgery & Psychiatry

1990

186

Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer.

J Grøndahl-Hansen, Harry A. Peters, W L van Putten,

PubMed

1995

174

Prognostic significance of cathepsins B and L in primary human breast cancer.

John A. Foekens, Janko Kos, Harry A. Peters,

Journal of Clinical Oncology

1998

147

Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.

Bob Löwenberg, M. Boogaerts, Simon Daenen,

Journal of Clinical Oncology

1997

128

Page 1